>
Switch to:

Allergy Therapeutics Accounts Payable & Accrued Expense

: $9.4 Mil (As of Jun. 2021)
View and export this data going back to 2004. Start your Free Trial

Allergy Therapeutics's quarterly accounts payable & accrued expense increased from Jun. 2020 ($8.4 Mil) to Dec. 2020 ($19.0 Mil) but then declined from Dec. 2020 ($19.0 Mil) to Jun. 2021 ($9.4 Mil).

Allergy Therapeutics's annual accounts payable & accrued expense increased from Jun. 2019 ($7.8 Mil) to Jun. 2020 ($8.4 Mil) and increased from Jun. 2020 ($8.4 Mil) to Jun. 2021 ($9.4 Mil).


Allergy Therapeutics Accounts Payable & Accrued Expense Historical Data

The historical data trend for Allergy Therapeutics's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allergy Therapeutics Annual Data
Trend Jun12 Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21
Accounts Payable & Accrued Expense
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.90 7.47 7.79 8.42 9.36

Allergy Therapeutics Semi-Annual Data
Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21
Accounts Payable & Accrued Expense Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.79 16.91 8.42 19.02 9.36

Allergy Therapeutics Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.


Allergy Therapeutics Business Description

Allergy Therapeutics logo
Industry
Traded in Other Exchanges
Address
Dominion Way, Worthing, West Sussex, GBR, BN14 8SA
Allergy Therapeutics PLC is active in the healthcare sector in the United Kingdom. It is a pharmaceutical company mainly engaged in the treatment and prevention of allergy with aluminium-free products. The company's geographical segment includes Central Europe; Southern Europe and the Rest of the World. It generates maximum revenue from Central Europe which includes Germany and other countries.

Allergy Therapeutics Headlines

No Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)